Mumbai, Oct. 6 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Deflazacort oral suspension (USRLD: Emflaza Oral Suspension, 22.75 mg/mL).

Published by HT Digital Content Services with permission from Capital Market....